Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antigens, Bacterial | 7 | 2019 | 330 | 1.24 | Why? |
| Streptococcus pneumoniae | 6 | 2019 | 827 | 0.91 | Why? |
| Bacterial Vaccines | 2 | 2019 | 139 | 0.84 | Why? |
| Meningococcal Vaccines | 6 | 2019 | 225 | 0.82 | Why? |
| Pneumococcal Vaccines | 6 | 2019 | 571 | 0.79 | Why? |
| Antibodies, Bacterial | 8 | 2019 | 510 | 0.72 | Why? |
| Pneumonia, Pneumococcal | 2 | 2019 | 251 | 0.71 | Why? |
| Neisseria meningitidis, Serogroup B | 5 | 2019 | 66 | 0.69 | Why? |
| Staphylococcal Vaccines | 3 | 2019 | 13 | 0.57 | Why? |
| Meningococcal Infections | 4 | 2018 | 216 | 0.53 | Why? |
| Drug Resistance, Microbial | 1 | 2018 | 419 | 0.53 | Why? |
| Polysaccharides, Bacterial | 3 | 2018 | 59 | 0.41 | Why? |
| Viral Vaccines | 3 | 2020 | 7560 | 0.39 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.35 | Why? |
| Heptavalent Pneumococcal Conjugate Vaccine | 2 | 2018 | 64 | 0.35 | Why? |
| Bacterial Proteins | 4 | 2018 | 1318 | 0.34 | Why? |
| Meningitis, Meningococcal | 2 | 2019 | 114 | 0.33 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.32 | Why? |
| Neisseria meningitidis | 2 | 2018 | 229 | 0.32 | Why? |
| Immune Sera | 1 | 2011 | 884 | 0.31 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.30 | Why? |
| Immunogenicity, Vaccine | 6 | 2021 | 4624 | 0.30 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.28 | Why? |
| Staphylococcus aureus | 3 | 2019 | 844 | 0.25 | Why? |
| Vaccines, Conjugate | 3 | 2019 | 328 | 0.24 | Why? |
| Staphylococcal Infections | 3 | 2019 | 1099 | 0.21 | Why? |
| Antibodies, Neutralizing | 8 | 2021 | 25288 | 0.21 | Why? |
| Blood Bactericidal Activity | 2 | 2017 | 19 | 0.21 | Why? |
| Bacteremia | 1 | 2011 | 1372 | 0.20 | Why? |
| Ethylene Glycols | 1 | 2017 | 7 | 0.18 | Why? |
| Immunoglobulin G | 9 | 2021 | 21571 | 0.17 | Why? |
| Th1 Cells | 2 | 2021 | 1228 | 0.17 | Why? |
| Carrier State | 2 | 2019 | 2100 | 0.17 | Why? |
| Immunization, Secondary | 3 | 2020 | 1649 | 0.16 | Why? |
| Macaca | 1 | 2017 | 388 | 0.15 | Why? |
| Single-Blind Method | 4 | 2020 | 1283 | 0.14 | Why? |
| Antibodies, Viral | 9 | 2021 | 51949 | 0.13 | Why? |
| B-Lymphocytes | 2 | 2018 | 4418 | 0.12 | Why? |
| Injections, Intramuscular | 3 | 2021 | 800 | 0.12 | Why? |
| Vaccines, Synthetic | 6 | 2021 | 3231 | 0.12 | Why? |
| Immunoassay | 2 | 2018 | 4485 | 0.12 | Why? |
| Immunization, Passive | 3 | 2021 | 10067 | 0.12 | Why? |
| Opsonin Proteins | 1 | 2011 | 18 | 0.11 | Why? |
| Clostridium Infections | 1 | 2019 | 595 | 0.11 | Why? |
| Pharynx | 1 | 2018 | 1544 | 0.11 | Why? |
| Pneumococcal Infections | 1 | 2017 | 562 | 0.11 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.10 | Why? |
| Rodent Diseases | 1 | 2011 | 115 | 0.10 | Why? |
| Animals, Newborn | 1 | 2011 | 350 | 0.10 | Why? |
| Vaccination | 7 | 2021 | 19050 | 0.10 | Why? |
| Phagocytosis | 1 | 2011 | 409 | 0.09 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.09 | Why? |
| Healthy Volunteers | 3 | 2019 | 1444 | 0.09 | Why? |
| Immunization Schedule | 3 | 2019 | 1305 | 0.09 | Why? |
| Mass Vaccination | 1 | 2018 | 1101 | 0.09 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.08 | Why? |
| Serum | 2 | 2018 | 294 | 0.08 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.08 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.08 | Why? |
| Adolescent | 13 | 2021 | 86841 | 0.07 | Why? |
| Immunity, Cellular | 1 | 2018 | 3614 | 0.07 | Why? |
| Serogroup | 2 | 2018 | 510 | 0.07 | Why? |
| Male | 17 | 2021 | 367725 | 0.06 | Why? |
| Female | 17 | 2021 | 380317 | 0.06 | Why? |
| Rats | 1 | 2011 | 2764 | 0.06 | Why? |
| Animals | 6 | 2021 | 78931 | 0.06 | Why? |
| Humans | 27 | 2021 | 930598 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 6 | 2021 | 37182 | 0.06 | Why? |
| Adult | 13 | 2021 | 244371 | 0.06 | Why? |
| Solubility | 1 | 2021 | 382 | 0.05 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.05 | Why? |
| Perineum | 1 | 2019 | 70 | 0.05 | Why? |
| Interleukin-2 | 1 | 2021 | 443 | 0.05 | Why? |
| Periplasmic Binding Proteins | 1 | 2017 | 2 | 0.04 | Why? |
| Coagulase | 1 | 2017 | 44 | 0.04 | Why? |
| Gambia | 1 | 2017 | 145 | 0.04 | Why? |
| Immunologic Memory | 2 | 2021 | 3362 | 0.04 | Why? |
| Survival Analysis | 1 | 2011 | 7592 | 0.04 | Why? |
| Quebec | 1 | 2018 | 498 | 0.04 | Why? |
| Double-Blind Method | 2 | 2019 | 5988 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| Placebos | 1 | 2019 | 629 | 0.04 | Why? |
| Bacteriological Techniques | 1 | 2018 | 239 | 0.04 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.04 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2017 | 593 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Drug Compounding | 1 | 2017 | 386 | 0.04 | Why? |
| Protein Multimerization | 1 | 2021 | 1336 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Immunization Programs | 2 | 2018 | 2006 | 0.03 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 497 | 0.03 | Why? |
| Recombinant Proteins | 2 | 2017 | 3786 | 0.03 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2021 | 5837 | 0.03 | Why? |
| Aged | 6 | 2020 | 215776 | 0.03 | Why? |
| Vaccines, Subunit | 1 | 2019 | 1088 | 0.03 | Why? |
| Australia | 2 | 2019 | 6306 | 0.03 | Why? |
| Complement System Proteins | 1 | 2017 | 380 | 0.03 | Why? |
| Pain | 1 | 2021 | 1084 | 0.03 | Why? |
| Microbial Viability | 1 | 2017 | 406 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2019 | 1218 | 0.03 | Why? |
| Child | 5 | 2021 | 70012 | 0.03 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.03 | Why? |
| Oropharynx | 1 | 2019 | 1581 | 0.03 | Why? |
| Clinical Trials as Topic | 2 | 2021 | 7330 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Headache | 1 | 2020 | 2257 | 0.03 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.02 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Immunization | 1 | 2018 | 2019 | 0.02 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.02 | Why? |
| Internationality | 1 | 2021 | 3297 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Single-Cell Analysis | 1 | 2017 | 2450 | 0.02 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.02 | Why? |
| Cross Reactions | 1 | 2018 | 4374 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Japan | 1 | 2019 | 6653 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Cell Line | 1 | 2021 | 12040 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| Germany | 1 | 2020 | 9196 | 0.02 | Why? |
| Antibody Formation | 1 | 2018 | 4038 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Aging | 1 | 2021 | 3581 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.02 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.02 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2013 | 1261 | 0.02 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Mice | 1 | 2021 | 21357 | 0.01 | Why? |
| Fever | 1 | 2017 | 7795 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| France | 1 | 2017 | 12074 | 0.01 | Why? |
| Students | 1 | 2018 | 5255 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
Jansen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(147)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(180)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_